Neurosoft Software Production (NRST) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of Neurosoft Software Production €1.30, price €0.58, upside +126.1%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Neurosoft Software Production for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range €0.4600 – €1.52 · fair‑value band €0.9700 – €1.63 · the €0.5750 price screens below the €1.30 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow Neurosoft Software Production in your weekly email
Every Wednesday you see whether Neurosoft Software Production is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Neurosoft Software Production S.A., an ICT company, provides managed and integrated services in Greece and internationally. It operates through Cyber Security Operations, Infrastructure & Cloud Operations, and Field Services Operations segments.
Show more
Neurosoft Software Production S.A., an ICT company, provides managed and integrated services in Greece and internationally. It operates through Cyber Security Operations, Infrastructure & Cloud Operations, and Field Services Operations segments. The company offers offensive cybersecurity services, such as applications security, cloud security, infrastructure security assessment, ATM, kiosk, thin client, red and purple teaming, ransomware simulation, assume breach, workstation defense evaluation, password cracking, and vulnerability assessment; defensive cybersecurity services, including SOCaaS, managed detection and response, incident response, digital forensics analysis, cyber threat intelligence, and OT security service; and advisory services comprising CISOaaS, security awareness, compliance readiness, risk assessments, tabletop exercises, ransomware readiness assessment, and third party risk management services. It also provides infrastructure services, which includes architecture and design, infrastructure deployment, secure network connectivity, data center and cloud, security platforms, communication and collaboration, and business continuity and disaster recovery services; network management, infrastructure management, IT and cloud operations, security solutions management, patch and configuration management, observability and performance optimization, infrastructure lifecycle management operation services; and security services, such as zero trust network architecture, critical infrastructure and OT, Identity, Information, AI, SDLC security, and secure digital workplace. In addition, the company offers rollout, preventive, corrective, and logistic and warehousing field services. Neurosoft Software Production S.A. was founded in 1994 and is headquartered in Athens, Greece.
Stock analysis
Neurosoft Software Production (NRST) currently trades at €0.5750, while our model-based Fair Value estimate is €1.30, implying the stock looks roughly 55.8% undervalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of €1.90 per share, and 22 of the 24 models we run sit above the €0.5750 price.
Bear case: the Asset-Based group reads lowest at €0.2500, and 2 of the 24 models stay below the price. Evidence for this calculation is low.
Scenario range: €0.9700 (bear) to €1.63 (bull), the price of €0.5750 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Neurosoft Software Production reported revenue of €34.7M in FY2025 versus €15.8M in FY2021, a compound +21.8%/yr. Reported net income was €1.2M in FY2025, compounding +7.3%/yr from FY2021.
Key figures
Market cap €16.8M · P/E ratio 11.5 · P/S ratio 0.39 · EPS (TTM) €0.0500 · Net margin 3.4% · Return on equity 13.4% · Return on assets (EBIT) 9.1% · Operating margin 8.8%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 24% below its 52-week high and 2% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Technology peers we cover trades at 44% fair-value upside, at 126%, NRST screens cheaper than that median.
Fair Value models
Bear €0.9700Fair Value €1.30Bull €1.63
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then (€0.0377 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.84/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
−8.4%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.7%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+18.7%
Start year 2020 (pandemic). Over 10 years: +10.8% a year
Revenue growth 19 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+16.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
What shareholders gained per year (last 5 years) ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate.
+5.8%
Earnings growth per share plus dividend.
Earnings per share, growth per year+5.8%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.5.8% vs −4.9%, picking up
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.−17% → 5%
Start year 2020 (pandemic)
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−8.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (euro area: IMF forecast 2.2% a year to 2030, 2.6% from 2016 to 2025) that is about −10.2% a year for the price.
Compare Neurosoft Software Production with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Information Technology Services · 461 stocks
Beats the industry median on 10/12 measures
Overall it ranks above its industry peers.
Valuation
Quality Score57 · Above median
Fair Value upside+126.1% · Top 25%
Profitability
Return on equity (TTM)13.4% · Above median
Return on assets5.1% · Above median
Net margin (TTM)3.4% · Below median
Operating margin (TTM)8.8% · Above median
Growth and dividend
Revenue growth−13.6% · Bottom 25%
Valuation Multiplesvs Information Technology Services median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Neurosoft Software Production Fair Value". https://www.fairvalue-calculator.com/stock/NRST
Frequently asked questions
Is Neurosoft Software Production (NRST) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of €1.30 versus a price of €0.5750, about +126% upside (undervalued).
What is the fair value of NRST?
Our model-based fair value for Neurosoft Software Production is €1.30 (as of Sep 27, 2026), built from audited fundamentals. The current price: €0.5750.
What is the quality score of NRST?
Neurosoft Software Production has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Neurosoft Software Production (NRST)?
Our model-based price target is the fair value of €1.30 (as of Sep 27, 2026) from 24 valuation models. Cautious scenario €0.9700, optimistic scenario €1.63. It is a calculation from audited fundamentals, not an analyst target.
What is the Neurosoft Software Production stock forecast for 2026?
Our models put fair value at €1.30, about +126% upside versus a price of €0.5750 (undervalued). Cautious scenario €0.9700, optimistic scenario €1.63. The calculation is refreshed regularly with new filings.
What is the revenue of Neurosoft Software Production (NRST)?
Neurosoft Software Production reported trailing-twelve-month revenue of about €34.7M (latest available figure, as of Sep 27, 2026).
What growth is priced into Neurosoft Software Production (NRST)?
For today's price to be fair in a discounted-cash-flow model, Neurosoft Software Production would have to grow free cash flow by -8.3 % per year for five years (discount rate 11.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +18.7 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of NRST use?
Our models discount Neurosoft Software Production at 11.4 %: a base by market capitalisation (nano), damped by beta 0.81, country premium for Italy. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Neurosoft Software Production that is -8.3 % per year a year over ten years, using the same discount rate (11.4 %) and the same formula as our fair value.
How much growth has Neurosoft Software Production (NRST) delivered so far?
Over the past 5 years revenue at Neurosoft Software Production grew +18.7 % a year. The price currently implies -8.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Neurosoft Software Production (NRST) growing?
The median revenue growth in the sector is +9.6 % a year. That is the yardstick for the growth priced into Neurosoft Software Production (-8.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Neurosoft Software Production (NRST)?
The free-cash-flow yield on the price is 13.74 %: that much free cash flow Neurosoft Software Production produces per unit of market value. When it exceeds the discount rate of our models (11.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Neurosoft Software Production (NRST)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Neurosoft Software Production it is €1.30 per share (as of Sep 27, 2026), against a price of €0.5750. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Neurosoft Software Production stock overvalued or undervalued in 2026?
As of Sep 27, 2026, NRST trades below its calculated fair value: price €0.5750, fair value €1.30, a gap of about +126% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of NRST?
No. The price is what the market pays today (€0.5750); the fair value is what the company's own numbers justify (€1.30). For Neurosoft Software Production the two are €0.7250 per share apart. That gap is exactly why we show both numbers side by side.
How much is Neurosoft Software Production worth?
The market values Neurosoft Software Production at about €16.8M (market capitalisation, as of Sep 27, 2026). Per share that is €0.5750; our models calculate a fair value of €1.30 per share.
What do the bullish and bearish scenarios say about NRST?
Our models span a range for Neurosoft Software Production: cautious scenario €0.9700, base €1.30, optimistic €1.63 per share (as of Sep 27, 2026, price €0.5750). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of NRST?
Neurosoft Software Production trades at a price-to-earnings ratio of 11.5 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of €1.30 is built from several models across several years. Other multiples: P/B 1.8, P/S 0.5, EV/EBITDA 7.0.
How solid is the balance sheet of Neurosoft Software Production (NRST)?
Balance-sheet figures for Neurosoft Software Production (as of Sep 27, 2026): return on equity 13.4%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is NRST from its 52-week high?
Neurosoft Software Production trades at €0.5750, about 24% below its 52-week high of €0.7600 and 2% above the low of €0.5650 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of €1.30 is for.
Which stocks are comparable to Neurosoft Software Production?
From the same area (Technology) we also value International Business Machines Corporation, Accenture plc, Tata Consultancy Services Limited, Infosys Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Neurosoft Software Production stock attractive at the current price?
The data as of Sep 27, 2026: price €0.5750, calculated fair value €1.30 (+126%), Quality Score 57/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of NRST calculated?
We run Neurosoft Software Production through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of €1.30, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. Neurosoft Software Production currently trades 56 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Neurosoft Software Production (NRST)?
The closing price on Oct 1, 2026 was €0.5750. Our model-based fair value is €1.30, about +126% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Neurosoft Software Production right now?
The price is below even our cautious bear case (€0.9700). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid quality (57/100) at a price below fair value, the discount is the argument here, not the business quality.
Key figures of Neurosoft Software Production
How large is the market capitalisation of Neurosoft Software Production (NRST)?
The market capitalisation of Neurosoft Software Production is €16.8M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Neurosoft Software Production (NRST)?
The price-to-sales ratio of Neurosoft Software Production is 0.39 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Neurosoft Software Production (NRST)?
Earnings per share at Neurosoft Software Production are €0.0500 (price ÷ EPS = P/E 11.5). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of Neurosoft Software Production (NRST)?
The net margin of Neurosoft Software Production is 3.4% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Neurosoft Software Production (NRST)?
The return on equity (ROE) of Neurosoft Software Production is 13.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Neurosoft Software Production (NRST)?
On an EBIT basis the return on assets of Neurosoft Software Production is 9.1% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Neurosoft Software Production (NRST)?
The operating margin of Neurosoft Software Production is 8.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Neurosoft Software Production (NRST)?
Revenue at Neurosoft Software Production is growing −13.6% versus a year earlier (3y avg +14.7%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Neurosoft Software Production (NRST)?
Earnings per share at Neurosoft Software Production are growing −22.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Neurosoft Software Production (NRST) hold?
Neurosoft Software Production holds more cash than debt, €2.9M net (fiscal year 2022). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Neurosoft Software Production in the live analysis
One click puts Neurosoft Software Production on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
